{
  "actions": [
    {
      "acted_at": "2019-04-29",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2019-04-29",
      "action_code": "H11100",
      "committees": [
        "HSJU"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the House Committee on the Judiciary.",
      "type": "referral"
    },
    {
      "acted_at": "2019-04-30",
      "action_code": "",
      "committees": [
        "HSJU"
      ],
      "references": [],
      "text": "Committee Consideration and Mark-up Session Held.",
      "type": "action"
    },
    {
      "acted_at": "2019-04-30",
      "action_code": "",
      "committees": [
        "HSJU"
      ],
      "references": [],
      "status": "REPORTED",
      "text": "Ordered to be Reported by Voice Vote.",
      "type": "ordered-reported"
    },
    {
      "acted_at": "2020-12-24",
      "action_code": "H12200",
      "committees": [
        "HSJU"
      ],
      "references": [],
      "text": "Reported by the Committee on Judiciary. H. Rept. 116-694.",
      "type": "action"
    },
    {
      "acted_at": "2020-12-24",
      "action_code": "H12410",
      "calendar": "Union",
      "number": "577",
      "references": [],
      "text": "Placed on the Union Calendar, Calendar No. 577.",
      "type": "calendar",
      "under": null
    }
  ],
  "amendments": [],
  "bill_id": "hr2374-116",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [
    "H. Rept. 116-694"
  ],
  "committees": [
    {
      "activity": [
        "reporting",
        "markup",
        "referral"
      ],
      "committee": "House Judiciary",
      "committee_id": "HSJU"
    }
  ],
  "congress": "116",
  "cosponsors": [
    {
      "bioguide_id": "C001084",
      "district": "1",
      "name": "Cicilline, David N.",
      "original_cosponsor": true,
      "sponsored_at": "2019-04-29",
      "state": "RI",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "C001068",
      "district": "9",
      "name": "Cohen, Steve",
      "original_cosponsor": false,
      "sponsored_at": "2019-04-30",
      "state": "TN",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "C001093",
      "district": "9",
      "name": "Collins, Doug",
      "original_cosponsor": true,
      "sponsored_at": "2019-04-29",
      "state": "GA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "N000002",
      "district": "10",
      "name": "Nadler, Jerrold",
      "original_cosponsor": true,
      "sponsored_at": "2019-04-29",
      "state": "NY",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "P000599",
      "district": "8",
      "name": "Posey, Bill",
      "original_cosponsor": false,
      "sponsored_at": "2019-12-09",
      "state": "FL",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "S000244",
      "district": "5",
      "name": "Sensenbrenner, F. James, Jr.",
      "original_cosponsor": true,
      "sponsored_at": "2019-04-29",
      "state": "WI",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "W000800",
      "district": "0",
      "name": "Welch, Peter",
      "original_cosponsor": true,
      "sponsored_at": "2019-04-29",
      "state": "VT",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": true,
    "active_at": "2019-04-30",
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2019-04-29",
  "number": "2374",
  "official_title": "To enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition and facilitate the efficient review of petitions filed in good faith to raise legitimate public heath concerns, and for other purposes.",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "s1224-116",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    },
    {
      "bill_id": "s3384-116",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    }
  ],
  "short_title": "Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act",
  "sponsor": {
    "bioguide_id": "J000294",
    "district": "8",
    "name": "Jeffries, Hakeem S.",
    "state": "NY",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REPORTED",
  "status_at": "2019-04-30",
  "subjects": [
    "Administrative law and regulatory procedures",
    "Business ethics",
    "Civil actions and liability",
    "Competition and antitrust",
    "Drug safety, medical device, and laboratory regulation",
    "Federal Trade Commission (FTC)",
    "Health",
    "Licensing and registrations",
    "Public participation and lobbying"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Reported to House",
    "asOf": "2020-12-24",
    "date": "2021-09-12T15:50:14Z",
    "text": "Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act or the Stop STALLING Act\n\nThis bill makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug. The bill authorizes the Federal Trade Commission to sue an individual or entity that submits such a petition to the FDA. A party found liable in such a lawsuit shall be subject to civil penalties, such as a fine of up to $50,000 for each day that the FDA spent reviewing the baseless petition."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Stop STALLING Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition and facilitate the efficient review of petitions filed in good faith to raise legitimate public heath concerns, and for other purposes.",
      "type": "official"
    },
    {
      "as": "reported to house",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act",
      "type": "short"
    },
    {
      "as": "reported to house",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Stop STALLING Act",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Stop STALLING Act",
      "type": "short"
    }
  ],
  "updated_at": "2023-01-11T13:44:08Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/hr/BILLSTATUS-116hr2374.xml"
}